Published on 4 Jan 2024 on Simply Wall St. via Yahoo Finance
LifeMD, Inc. (NASDAQ:LFMD) Shares Could Be 32% Above Their Intrinsic Value Estimate
Key Insights
Using the 2 Stage Free Cash Flow to Equity, LifeMD fair value estimate is US$5.89LifeMD's US$7.77 share price signals that it might be 32% overvalued The US$10.20 analyst price target for LFMD is 73% more than our estimate of fair value
How far off is LifeMD, Inc. (NASDAQ:LFMD) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine.